Viewing Study NCT02312557


Ignite Creation Date: 2025-12-24 @ 6:36 PM
Ignite Modification Date: 2026-04-17 @ 12:08 PM
Study NCT ID: NCT02312557
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-03
First Post: 2014-12-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide
Sponsor: OHSU Knight Cancer Institute
Organization: